UK markets closed

Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
67.10-0.67 (-0.99%)
At close: 03:28PM IST

Biofil Chemicals and Pharmaceuticals Limited

11/12, Sector "E"
Sanwer Road Industrial Area
Indore 452015
India
91 73 1272 3016
https://www.biofilgroup.net

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees47

Key executives

NameTitlePayExercisedYear born
Mr. Pavan Singh RajputChief Financial OfficerN/AN/A1991
Mr. Ketan ShahCOO & Whole Time Director1.74MN/A1961
Ms. Shweta VermaCompany Secretary & Compliance officerN/AN/AN/A
Mr. Ramesh S. ShahChairman, CEO & MDN/AN/A1936
Joseph ChackoHead of AdministrationN/AN/A1961
Akshay AtriMarketing ManagerN/AN/A1991
Vinayak BhopteChief ChemistN/AN/A1974
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.

Corporate governance

Biofil Chemicals and Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.